Work

CD40L disruption enhances Aβ vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammation

Year: 2007

Type: article

Source: Neurobiology of Disease

DOI: 10.1016/j.nbd.2007.09.009

Authors: D. Obregon, H. Hou, Y. Bai, W.V. Nikolic, T. Mori, Deyan Luo, J. Zeng, J. Ehrhart, F. Fernandez, D. Morgan, B. Giunta, T. Town, J. Tan

Institutions: Saitama Medical University, University of South Florida, Yale University

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute on Aging, National Institute of Neurological Disorders and Stroke

Awards: G2385400721, Aminergic Function in Brain Aging and Alzheimer's Disease, Blocking TGF-Beta immune signaling as a therapeutic target for Alzheimer's diseas, Implication of HUCBC: a novel therapeutic strategy for Alzheimer's disease, CD40 Modulation of Abeta-Vaccine Immune Response

OpenAlex ID: W2160802690

FWCI: 3.784

Cites: 68

Cited by: 29

Related to: 10